Select Page

Ibnsina Pharma’s EGM approves capital raise to EGP 280 million

The extraordinary general meeting (EGM) of “Ibnsina Pharma” has agreed on increasing the company’s issued capital to EGP 280 million from EGP 240 million, through the issuance of bonus shares.

The company’s issued capital is distributed over 1.12 million shares, at a nominal value of EGP 0.25 per share.